Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
UYgWWeLzgwYPLkmF